AnPac Bio-Medical Science Co., Ltd.
ANPCNASDAQHealthcare
$4.30
$-0.14(-3.15%)
Market Cap$26974846
P/E Ratio—
52W High$11.99
52W Low$2.6
AnPac Bio-Medical Science Co., Ltd. (ANPC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ANPC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $12.04M | $17.99M | $20.51M | $10.85M | $10.25M |
| Cost of Revenue | $3.71M | $5.73M | $7.63M | $6.05M | $5.67M |
| Gross Profit | $8.34M | $12.25M | $12.88M | $4.80M | $4.58M |
| Gross Margin %(computed) | 69.21% | 68.13% | 62.81% | 44.24% | 44.66% |
| Operating Expenses | |||||
| R&D Expenses | $9.53M | $16.20M | $11.58M | $9.84M | $10.11M |
| G&A Expenses | $70.79M | $80.68M | $74.76M | $70.78M | $28.85M |
| Total Operating Expenses | $92.47M | $118.30M | $106.01M | $93.88M | $48.19M |
| Operating Income | ($84.14M) | ($106.05M) | ($93.13M) | ($89.08M) | ($43.61M) |
| Operating Margin %(computed) | -698.59% | -589.60% | -454.07% | -821.41% | -425.45% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.37M | $4.26M | $1.14M | $2.61M | $0.93M |
| Income Before Tax | ($105.73M) | ($121.27M) | ($80.65M) | ($101.84M) | ($42.49M) |
| Income Tax Expense | ($2.13M) | ($1.18M) | ($0.09M) | ($0.22M) | ($0.20M) |
| Net Income | ($103.60M) | ($120.09M) | ($80.56M) | ($101.62M) | ($42.06M) |
| Net Margin %(computed) | -860.16% | -667.67% | -392.83% | -937.03% | -410.37% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-54.18 | $-176.53 | $-143.99 | $-205.96 | $-3.76 |
| Wtd Avg Shares | 1.91M | 0.68M | 0.56M | 0.49M | 11.20M |
| EBITDA | ($99.62M) | ($112.10M) | ($77.41M) | ($93.35M) | ($38.19M) |
| EBITDA Margin %(computed) | -827.12% | -623.25% | -377.46% | -860.74% | -372.61% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CNY · M
Explore more AnPac Bio-Medical Science Co., Ltd. data
About AnPac Bio-Medical Science Co., Ltd. (ANPC) Income Statement
AnPac Bio-Medical Science Co., Ltd. (ANPC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, ANPC reported revenue of $0.01B, gross profit of $0.01B (gross margin 69.21%), and net income of ($0.10B) — a net profit margin of -860.16%.
Frequently asked questions
ANPC · 4 questionsAnPac Bio-Medical Science Co., Ltd. (ANPC) reported revenue of $0.01B for 2022, down 33.0% year-over-year.
ANPC revenueANPC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09